New Book “Transforming Our World” Offers First-Hand Insights, Lessons Learned From Deft Foreign Policy of George H.W. Bush

The Texas A&M University System News Release

All-Star Lineup of Diplomat Authors Includes James A. Baker III, Condoleeza Rice

BRYAN-COLLEGE STATION, Texas — In a single term as president, George H.W. Bush led the western world through one its most consequential periods — the fall of the Soviet Union and the reunification of Germany that marked the peaceful end of the Cold War.

As the 41st president from 1989 to 1993, Bush’s deft decision-making cemented the world order for a generation. His foreign policy leadership is examined like never before in a newly published book.

“Transforming Our World” was edited by Andrew S. Natsios and Andrew H. Card Jr., two Bush 41 administration officials associated with the Bush School of Government and Public Service at Texas A&M University.

It features first-hand accounts from 18 former Bush 41 administration officials, including his Secretary of State James A. Baker III, and Condoleeza Rice, who served on the Bush 41 National Security Council before being Secretary of State for President George W. Bush (2005-2009.)

The essays combine to provide unique, behind-the-scenes perspective on Bush 41’s role in world events, his style of diplomacy, leadership and management skills, and the generational consequences of his decisions.

“There is no better nor more comprehensive examination of President George H. W. Bush’s extraordinary foreign policy record than ‘Transforming Our World,’” said Robert M. Gates, former Secretary of Defense (2006-2001) and CIA Director (1991-1993). He also served as Texas A&M President (2002-2006) and as Dean of the Bush School (2001-2002). “It brings to life for the reader the remarkable team Bush assembled, how he made historic decisions, and, indeed, how he transformed our world.”

The current Dean of the Bush School, retired Air Force General Mark Welsh, said that “Transforming Our World” has vital lessons for present and future public officials.

“As we try to make sense of today’s strategic landscape,” said Welsh, a former Air Force Chief of Staff (2012-2016), “the steady leadership and thoughtful decisions reflected in this book serve as wonderful examples of how leaders can best serve our nation and our world.”

Natsios served Bush 41 as Director of USAID’s Office of U.S. Foreign Disaster Assistance, where he oversaw the U.S. relief effort in several humanitarian emergencies. He is an executive professor at the Bush School and director of its Scowcroft Institute of International Affairs.

Card served Bush 41 as Deputy Chief of Staff and later Secretary of Transportation. He also has served as Acting Dean of the Bush School and, until last month, was interim CEO of the George & Barbara Bush Foundation.

About the Bush School of Government and Public Service
The Bush School of Government and Public Service was founded in 1997 to honor the nation’s 41st president.  Its mission is to prepare future leaders for careers in government and other forms of public service. Bush School offerings consistently rank among the best international affairs and public service graduate programs in the nation.  The School is located next to the George H.W. Bush Presidential Library and Museum in College Station and offers degree programs and curriculum in-person, online and through a teaching site in Washington D.C.

About The Texas A&M University System
The Texas A&M University System is one of the largest systems of higher education in the nation with a budget of $6.3 billion. The Texas A&M System is a statewide network of 11 universities; a comprehensive health science center; eight state agencies, including the Texas Division of Emergency Management; and the RELLIS Campus. The Texas A&M System educates more than 151,000 students and makes more than 22 million additional educational contacts each year. Systemwide, research and development expenditures exceeded $1 billion in FY 2019 and helped drive the state’s economy.

For more information, contact: Mike Reilly
Chancellor’s Office of Marketing and Communications
(979) 458-6492
(402) 679-0456
mreilly@tamus.edu

FUJIFILM Diosynth Biotechnologies Begins Production of Two COVID-19 Vaccines Candidates at Texas Facility

The Texas A&M University System News Release

Texas A&M System contract designates FUJIFILM Diosynth Biotechnologies facility for emergency federal use

BRYAN-COLLEGE STATION, Texas, January 11, 2021 – FUJIFILM Diosynth Biotechnologies, and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM) today announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government to meet Operation Warp Speed goals.

FUJIFILM Diosynth Biotechnologies Texas, a subcontractor of the CIADM, recently completed its capacity expansion at its Flexible Biomanufacturing Facility in College Station, Texas, to accommodate large-scale production of the COVID-19 vaccine candidates. FUJIFILM Diosynth Biotechnologies will produce bulk drug substance of NVX‑CoV2373, Novavax’ vaccine candidate, which began phase 3 clinical testing in the U.S. and Mexico in December, 2020. NVX-CoV2373- is already being manufactured at commercial scale at the company’s plant in Morrisville, North Carolina.

“After several months of intense preparation and hard work, we are ready to produce two vaccine candidates locally here in College Station,” said Dr. Gerry Farrell, Chief Operating Officer, FUJIFILM Diosynth Biotechnologies, Texas. “We are pleased to bring our technical expertise and world-class facilities to support the mission of Operation Warp Speed in bringing a safe and effective vaccine to the world.”

“The Texas A&M System is proud to be part of this unprecedented manufacturing effort,” said John Sharp, Chancellor of The Texas A&M System. “Our partnership with FUJIFILM Diosynth Biotechnologies confirms the importance of the CIADM program for Texas, the nation and the world.”

FUJIFILM Diosynth Biotechnologies owns and operates three facilities built through the CIADM program. As a subcontractor of the Texas A&M System, the facilities can be made available for emergency government use.

In July, the federal government reserved capacity at the College Station facility through the end of 2021 by tapping into an agreement with the CIADM. To enhance vaccine production, FUJIFILM Diosynth Biotechnologies accelerated its planned capacity expansion investments in the facility by several months. The facility is the largest scale-out cell culture manufacturing facility in the U.S. with a total of 14 2,000L cell culture trains.

To prepare for mass production of the vaccine candidates, FUJIFILM Diosynth Biotechnologies has added about 260 positions since April 2020, doubling its local workforce. The company plans to recruit another 50 positions.

“Our team has worked around the clock since July and we’re starting to see light at the end of the tunnel,” Farrell said. “There is great pride and satisfaction on our team for being part of the solution to the pandemic.”

The CIADM contract is with the Biomedical Advanced Research and Development Authority  (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS).

“This is a tremendous responsibility,” said Dr. W. Jay Treat, Texas A&M’s Chief Manufacturing Officer for the CIADM. “It’s gratifying for us to make a positive contribution in fighting the pandemic.”

Operation Warp Speed is a partnership among components of the HHS, the Department of Defense and other federal agencies, engaging with private firms, and coordinating among existing HHS-wide efforts to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.

About The Texas A&M University System
The Texas A&M University System is one of the largest systems of higher education in the nation with a budget of $6.3 billion. The System is a statewide network of 11 universities; a comprehensive health science center; eight state agencies, including the Texas Division of Emergency Management; and the RELLIS Campus. The Texas A&M System educates more than 151,000 students and makes more than 22 million additional educational contacts through service and outreach programs each year. System-wide, research and development expenditures exceeded $1 billion in FY 2019 and helped drive the state’s economy.

Texas A&M System Contact:
Mike Reilly
Office of Marketing and Communications
(979) 458-6492
(402) 679-0456 cell
mreilly@tamus.edu

About FUJIFILM
FUJIFILM Diosynth Biotechnologies is an industry-leading Biologics Contract Development and Manufacturing Organization (CDMO) with locations in Teesside, UK, RTP, North Carolina, College Station, Texas and Hillerød, Denmark. FUJIFILM Diosynth Biotechnologies has over thirty years of experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules, viral products and medical countermeasures expressed in a wide array of microbial, mammalian, and host/virus systems. The company offers a comprehensive list of services from cell line development using its proprietary pAVEway™ microbial and Apollo™X cell line systems to process development, analytical development, clinical and FDA-approved commercial manufacturing. FUJIFILM Diosynth Biotechnologies is a partnership between FUJIFILM Corporation and Mitsubishi Corporation.  For more information, go to: www.fujifilmdiosynth.com

FUJIFILM Corporation is an operating company of FUJIFILM Holdings Corporation. FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2020, the company had global revenues of $21 billion, at an exchange rate of 109 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com

Fujifilm Contact:
Christine Jackman
Fujifilm
(914) 261-4959
christine.jackman@fujifilm.com